Studies suggest that within-person changes in estrogen and progesterone predict changes in binge eating across the menstrual cycle. However, samples have been extremely small (maximum N ϭ 9), and analyses have not examined the interactive effects of hormones that are critical for changes in food intake in animals. The aims of the current study were to examine ovarian hormone interactions in the prediction of within-subject changes in emotional eating in the largest sample of women to date (N ϭ 196). Participants provided daily ratings of emotional eating and saliva samples for hormone measurement for 45 consecutive days. Results confirmed that changes in ovarian hormones predict changes in emotional eating across the menstrual cycle, with a significant estradiol ϫ progesterone interaction. Emotional eating scores were highest during the midluteal phase, when progesterone peaks and estradiol demonstrates a secondary peak. Findings extend previous work by highlighting significant interactions between estrogen and progesterone that explain midluteal increases in emotional eating. Future work should explore mechanisms (e.g., gene-hormone interactions) that contribute to both within-and betweensubjects differences in emotional eating.
increases palatable food intake (Klump et al., 2011b) and administration of a high-estradiol/low-progesterone treatment decreases intake of high-fat food (Yu, Geary, & Corwin, 2008) . Early attempts to model these same effects in humans examined differential rates of food intake, binge eating, and emotional eating (i.e., the tendency to eat excessive amounts of food for reasons that are typically endorsed by binge eaters) across menstrual cycle phases characterized by high estrogen (e.g., the follicular/ovulatory phases) versus high progesterone and high estrogen (e.g., the midluteal phase). Results consistently supported increased food intake, emotional eating, and binge eating during the midluteal phase as compared to the follicular/ovulatory phase (Buffenstein, Poppitt, McDevitt, & Prentice, 1995; Edler et al., 2007; Gladis & Walsh, 1987; Klump et al., 2008; Lester et al., 2003; Price, Torem, & DiMarzio, 1987) . Two pilot studies have directly assessed ovarian hormones and found that decreases in estradiol and increases in progesterone predict increases in emotional eating and binge eating (Edler et al., 2007) across the menstrual cycle. Hormone/binge eating associations were independent of body weight and daily changes in negative affect and were observed for binge episodes in women with bulimia nervosa (BN) (Edler et al., 2007) and emotional eating scores in a nonclinical sample of women . Thus, they appeared to be present across the full spectrum of dysregulated eating behavior.
Nonetheless, significant limitations of past studies highlight the need for replication. Most importantly, sample sizes in studies utilizing hormone assessments were very small (maximum N ϭ 9). In addition, these studies did not model the interactive effects of hormones on binge/emotional eating risk or confirm that the direction of association is from changes in hormones to changes in binge/emotional eating (rather than the reverse). Animal data strongly suggest that ovarian hormone effects are interactive and cause changes in food intake (Asarian & Geary, 2006) . Because menstrual cycle changes in estrogen and progesterone are dictated by the reproductive system, changes in hormones that predict changes in binge and emotional eating should reflect the impact of ovarian hormones on these behaviors rather than the reverse. However, translational studies that model the direction of effects and interactive processes are needed to confirm an etiologic role for ovarian hormones in binge eating and emotional eating risk.
The goal of the current study was to examine within-person associations between changes in hormones and emotional eating across the menstrual cycle in a large, community-based sample of women. We examined the main effects of estrogen and progesterone, as well as their interaction, to determine whether the complex associations observed in animals are present in humans. We analyzed models in which changes in hormones predicted changes in emotional eating, as well as models in which changes in emotional eating predicted changes in hormones. We controlled for body weight and negative affect to ensure that hormone effects were independent of these third variables. We focused on emotional eating rather than binge eating, since full binge episodes would be relatively uncommon in our community-based sample, and pilot studies show similar hormone/behavior relationships when analyzing binge frequency in women with BN (Edler et al., 2007) and emotional eating in community women . N ϳ 18,000 twins) . The MSUTR recruits twins through birth records using methods described previously (Klump & Burt, 2006) . Prior (Culbert, Breedlove, Burt, & Klump, 2008) and current analyses indicate that MSUTR twins are demographically representative of the recruitment region (89% Caucasian; 11% African American).
Method Participants
Inclusion/exclusion criteria ensured that we captured natural variations in hormones: 1) menstruation every 22-32 days for the past 6 months; 2) no hormonal contraceptive use in the past 3 months; 3) no psychotropic or steroid medications in the past 4 weeks; 4) no pregnancy or lactation within the past 6 months; and 5) no history of genetic or medical conditions known to influence hormone functioning or appetite/weight. Despite these criteria, disordered eating scores (e.g., emotional eating, body dissatisfaction) did not differ between our participants and other MSUTR twins (ds ϭ .02-.18).
Procedures
Participants collected data for 45 consecutive days. Salivary samples were collected every morning within 30 minutes of waking using published methods . Behavioral ratings were made each evening (after 5:00 p.m.) using an online data collection system or preprinted scantrons. The timing of data collection ensured that a given day's hormone collection preceded that day's behavioral ratings.
Three in-person visits occurred at the start of the study, midway through data collection (ϳDay 23), and at the end of data collection (ϳDay 45). Each visit included a reassessment of study eligibility, participant height/weight measurements, and collection of samples. Between visits, staff contacted participants once a week to answer questions and confirm protocol adherence. These procedures were effective for minimizing dropouts (3%) and missing data (Յ6%) and identifying twins who were no longer eligible (3% due to pregnancy or medication use). tial elevations across normal and abnormal groups, where the highest scores are observed in women with BN, followed by overweight women, then normal-weight women, and then women with anorexia nervosa (Wardle, 1987) . Similar to previous research , instructions were modified with permission to refer to that day (i.e., "true in relation to you TODAY"). Internal consistency of our modified version was excellent (average ␣ ϭ .90).
Negative affect. The Negative Affect scale from the Positive and Negative Affect Schedule (Watson, Clark, & Tellegen, 1988) was used to measure negative affect (i.e., depression and anxiety) each day. This scale exhibits good convergent and discriminant validity (Watson et al., 1988) and excellent internal consistency (average ␣ ϭ .85 in our sample).
Hormones. Hormone concentrations were measured in saliva. Saliva collection is a noninvasive method for repeated sampling schedules that is associated with higher compliance and more robust hormone-behavior associations than bloodspots (Edler et al., 2007) .
Salivary assays were conducted by Salimetrics, LLC (State College, PA) using enzyme immunoassay kits that show excellent intra-and interassay coefficients of variation (estradiol ϭ 7.1% and 7.5%; progesterone ϭ 6.2% and 7.6%), assay sensitivity (determined by interpolating the mean optical density minus 2 SDs of 10 -20 replicates at the 0 pg/mL level; estradiol ϭ 0.10 pg/mL; progesterone ϭ 5 pg/mL), and method accuracy (determined by spike recovery and linearity; estradiol ϭ 104.2% and 99.4%; progesterone ϭ 99.6% and 91.8%). In order to capture key periods of hormonal change (e.g., mid-late follicular through the premenstrual phase) while maximizing the number of subjects assessed, we assayed samples every other day during menstrual bleeding and the early follicular phase when hormone levels were expected to be low and stable.
Body mass index (BMI). BMI (weight [in kilograms]/height [in meters]
2 ) was calculated using height and weight measured during lab assessments with a wall-mounted ruler and digital scale, respectively.
Statistical Analyses
Data preparation. Analyses of within-person associations between changes in ovarian hormones and emotional eating were modeled after those used by Edler et al. (2007) and Klump et al. (2008) . Five-day rolling averages were calculated for hormones, emotional eating, negative affect, and BMI. Rolling averages reduce the influence of hormone pulsatility and increase the signalto-noise ratio by minimizing random environmental variations (e.g., decreased opportunities to binge eat) (Gladis & Walsh, 1987; Kassam et al., 1996; Waller et al., 1998) . Because BMI was assessed at only three time points, rolling averages were calculated using visit 1 BMI for days in between visits 1 and 2, visit 2 BMIs for days in between visits 2 and 3, and visit 3 BMI for the last assessment day (Day 45). Changes in weight across the study period were minimal (M ϭ Ϫ0.20 lb change, SD ϭ 3.39).
We then converted all of the rolling averages into within-person Z scores based upon each participant's overall mean and standard deviation across data collection. Previous studies (Edler et al., 2007; Gladis & Walsh, 1987; Klump et al., 2008; Lester et al., 2003) have focused on standardized values because they index the extent to which changes in a woman's hormones, relative to her equilibrium, predict changes away from her equilibrium in emotional eating. They also tend to be sensitive to small deviations from equilibria, making them ideal indicators of how withinperson changes in hormones predict changes in emotional eating in non-clinical samples of women.
Missing data were handled two ways. We prorated raw scores for behavioral measures when Յ10% of the items were missing, and coded the scores as missing if Ͼ10% of items were missing. We then calculated the behavioral and hormone rolling averages if Ն3 days of data were available within the 5-day window. If fewer than 3 days were available, then the average for that day was coded as missing (occurring Ͻ2.6% of the time).
Predictive associations. We used mixed linear models (MLMs) to examine cycle phase and hormone influences on emotional eating. MLMs are ideal for these analyses as we could examine predictive associations while controlling for covariates (i.e., negative affect and BMI) and the nonindependence of the repeated measures and twin data. We controlled for the nonindependence of the twin data by estimating random intercepts and allowing them to correlate.
1 Because most cotwins were assessed across the same 45-day period, we also estimated a time-specific dyadic correlation that allowed the twins' residual scores for emotional eating to correlate from day to day. For each of these random effects, we specified a compound symmetry covariance structure which estimates a single intercept variance or a single residual variance across twins and time. The models also allowed for random slopes for each of the predictors (i.e., hormones, negative affect, BMI). However, because there was no evidence that these slopes correlated across twins, we fixed the cross-twin correlation to zero for all predictors.
We first used the MLMs to replicate previous findings of higher emotional eating scores during the midluteal phase. Cycle phase (i.e., follicular, ovulatory, midluteal, premenstrual) was coded based on dates of menstrual bleeding and increases/decreases in hormones (see Edler et al. [2007] for coding methods). Potential phase differences were examined by including phase as a predictor of emotional eating in the MLMs.
We then used MLMs to examine within-person associations between changes in hormones and changes in emotional eating. We first fit a model that tested only the main effects of estradiol, progesterone, and the covariates (i.e., negative affect and BMI). We then fit a second model that included the estradiol ϫ progesterone interaction in addition to all main effects. In order to confirm the direction of association, we fit a third model where changes in emotional eating predicted changes in hormones.
Results
Fluctuations in emotional eating across the menstrual cycle were somewhat more modest than those observed in a clinical sample (Edler et al., 2007) , but they nevertheless replicated prior work showing the highest emotional eating scores during the midluteal phase and the lowest scores during the ovulatory phase (see Figure  1) . MLMs confirmed the presence of a significant phase effect, 1 To further ensure that our use of twins did not unduly influence results, we conducted analyses in samples of MZ and DZ twins only. The pattern of results was identical to that in the full sample (data not shown).
F(3, 5890) ϭ 6.57, p Ͻ .001, where emotional eating levels were significantly higher in the midluteal as compared to the ovulatory, t(2973) ϭ 4.32, p Ͻ .001 and premenstrual, t(2779) ϭ 3.11, p ϭ .002, phase. No significant differences in emotional eating were observed between the midluteal phase and follicular phase, t(4168) ϭ 0.52, p ϭ .61, although scores appeared to be higher in the midluteal phase.
Data in Figure 1 further suggest that changes in ovarian hormones account for these phase differences, as changes in emotional eating appeared to follow changes in hormones. In the main effects model, there was a trend (p ϭ .10) for higher levels of progesterone to predict higher emotional eating scores, even after controlling for the significant effects of both negative affect and BMI (see Table 1 ). This trend, however, became weaker (p ϭ .20) when the estradiol ϫ progesterone interaction was included. This interaction was significantly different from zero (p ϭ .007) and suggested that within-person changes in estradiol and progesterone interact to influence changes in emotional eating. Using the MLM beta weights (see methods in Dawson & Richter, 2006) , we graphed the estradiol ϫ progesterone interaction and showed that emotional eating scores are elevated when both progesterone and estradiol levels are high (see Figure 2 ). These findings map on to phase analyses showing the highest emotional eating scores during the midluteal phase-a phase characterized by the highest progesterone levels of the cycle and a secondary peak in estradiol. Results also corroborated animal work in intact rats suggesting that progesterone causes increased food intake in the presence of estradiol (Wade, 1972) ; in our data, progesterone had little-to-no effect on emotional eating when estradiol levels were low, but at high estradiol levels, there was a pronounced effect of progesterone on emotional eating. This would explain why emotional eating scores are not higher during the ovulatory phase when estradiol peaks, as progesterone is low during ovulation and is unable to counteract the protective effects of estradiol on emotional eating.
Models examining changes in emotional eating as predictors of hormones supported the hypothesis that the direction of effects is from the hormones to emotional eating rather than the reverse, as emotional eating was not a significant predictor of estradiol (b ϭ Ϫ.003 (.02), t(197) ϭ Ϫ0.10, p ϭ .92) or progesterone (b ϭ .03 (1.02), t(194) ϭ 1.02, p ϭ .31). To ensure that the ordering of our hormone and emotional eating assessments (i.e., hormones collected each morning; behavioral ratings made each evening) did not influence our results, we reran the models using 1-day timelagged scores to examine whether emotional eating on the previous night predicted changes in hormones the next morning. The effect of emotional eating was consistently nonsignificant in these models (ps Ͼ .10).
Because effects were more modest than observed previously in clinical samples (Edler et al., 2007) , we conducted post hoc analyses examining whether hormone/emotional eating associations are stronger in more disturbed groups (i.e., the top 33% [n ϭ 82] and 10% [n ϭ 23] of emotional eating scorers). Despite smaller sample sizes, patterns were nearly identical, with the estradiol ϫ progesterone interaction (top 33%: b ϭ .04 (.02), t(71) ϭ 1.60, p ϭ .11; top 10% group: b ϭ .06 (.04), t(471) ϭ 1.65, p ϭ .09) exerting a stronger influence on emotional eating scores than the hormone main effects (ps Ն .30). Interactions were strongest in the top 10% group where the beta was 33% higher than in the full sample, and more pronounced differences were observed between high versus low progesterone levels (see Figure 1) . The largest differences were still observed at high estradiol levels, although group differences were increased at low estradiol levels as well, where emotional eating scores were highest when progesterone levels were low. These findings again highlight the interactive effects of progesterone and estrogen, as progesterone's influence is limited to times when progesterone is high and estrogen is elevated as well.
Discussion
This is the largest study to date examining within-person changes in ovarian hormones and dysregulated eating across the menstrual cycle. Results replicated previous work suggesting elevated emotional eating scores during the midluteal phase and significant associations between changes in progesterone and emotional eating. More importantly, findings extended previous work by showing that interactions between estradiol and progesterone are the strongest predictors of within-subject changes in emotional eating. These interactive effects predicted increased emotional eating during hormonal milieus characterized by high progesterone and high estradiol levels in the full sample as well as more extreme groups.
Observed hormone effects were not a result of BMI or changing levels of negative affect, and the direction of association was from changes in hormones to changes in emotional eating. These findings are significant in suggesting potential causal associations between hormonal changes across the reproductive cycle and emotional eating. Moving forward, it will be important to confirm causal influences using a combination of animal and human research. Human research could track changes in binge/emotional eating in response to exogenously administered hormones, and animal studies could provide "purer" tests of hormone effects by administering hormones to ovariectomized animals. In both sets of studies, it will be critical to model the interactive effects of estrogen and progesterone on binge eating risk using physiologic doses of both estradiol and progesterone (Yu et al., 2008) to replicate and extend our work.
Associations between hormones and emotional eating were somewhat smaller than those observed in women with BN (Edler et al., 2007) . Our effect sizes were more on par with Klump et al.'s (2008) study of community women that found small-to-moderate associations between emotional eating scores, estradiol, and progesterone levels. Stronger effects in women with BN than community samples might be due to the higher frequency and greater severity of binge eating in clinical samples. Alternatively, differences in binge eating constructs (i.e., binge episodes in women with BN; emotional eating in community samples) could contribute to differential strengths of association. Although our emotional eating scale correlates with traditional binge eating measures and palatable food intake (see Method), scores on this dimensional measure do not assess binge episodes per se. Importantly, however, we obtained larger effect sizes when we examined our most extreme group, suggesting that differences in the severity of dysregulated eating may account for differences in the size of effects between clinical and community samples.
It is interesting to note that the differential strength of hormone/ eating associations across levels of severity may point to key etiological mechanisms. In particular, they suggest the possible presence of gene-environment interactions, in which changes in ovarian hormones predict changes in binge/emotional eating in women who are genetically vulnerable to these extreme phenotypes. This interpretation would help account for the fact that all women who are ovulating experience changes in hormones across the menstrual cycle, but only some develop full-blown binge eating. One primary function of ovarian hormones is to regulate gene transcription of several neurobiological systems disrupted in binge eating (e.g., serotonin) (Östlund, Keller, & Hurd, 2003;  Wilson, Foster, Kronenberg, & Larsen, 1998) . Data also suggest significant brain changes (e.g., increased gray matter volume) across the menstrual cycle (Hagemann et al., 2011 ) that correlate with changes in behavior (e.g., food intake, reward processing) and are thought to be due to the genomic effects of hormones (Protopopescu et al., 2005; Van Vugt, 2010) . Given our findings, it may be that associations between menstrual cycle changes in hormones and binge/emotional eating reflect hormone-induced changes in gene transcription in women who are genetically vulnerable to binge eating phenotypes. These genetic changes would become prominent only after hormonal activation at puberty and the onset of menstrual cycles-developmental periods that are associated with both increased phenotypic (Bulik, 2002; Klump et al., 2011a) as well as genetic (Culbert, Burt, McGue, Iacono, & Klump, 2009; Klump, Perkins, Burt, McGue, & Iacono, 2007) risk for binge eating.
Clearly, these hypotheses are speculative, as no studies have examined hormone-induced changes in genetic effects for binge eating or emotional eating. But they represent one set of possible explanations for our phenotypic findings and innovative hypotheses to be examined in future research. This work will need to determine when and for whom ovarian hormones are genetic risk factors for emotional eating by examining whether genetic risk predicts when a vulnerable woman will binge eat across her menstrual cycle as well as who is more likely to binge eat. Differentiation between the when and who will be critical for understanding both maintenance (i.e., mechanisms that explain when a woman is more likely to engage in emotional eating or binge eating) as well as etiologic mechanisms (i.e., factors predicting who is more likely to begin engaging in binge eating) that have important clinical implications. For example, our data and those of others (Edler et al., 2007; Lester et al., 2003) provide important information about when a woman is significantly more likely to binge eat or engage in emotional eating episodes (i.e., during the midluteal phase of her cycle). In women who are cycling, this high-risk period will occur very regularly (i.e., monthly) and should therefore be an important psychoeducational component of interventions for women with binge eating episodes as well as prevention campaigns aimed at increasing awareness of risk and triggers for dysregulated eating. However, new data on "when" and "who" mechanisms is also needed in order to identify new treatment targets (e.g., hormonal supplements in depression) (Benmansour, Weaver, Barton, Adeniji, & Frazer, 2012; Studd, 2011) and high-risk groups with the potential to significantly increase the effectiveness of intervention and prevention programs for a range of dysregulated eating.
